DiaSorin (DSRLF) News Today $109.01 0.00 (0.00%) As of 05/2/2025 Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartHeadlinesShort InterestBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period DiaSorin: Anticipate A Double-Digit EBITDA Growth RateMay 2 at 12:24 PM | seekingalpha.comDiaSorin (OTCMKTS:DSRLF) Hits New 52-Week Low - Here's WhyDiaSorin (OTCMKTS:DSRLF) Hits New 52-Week Low - Time to Sell?April 16, 2025 | marketbeat.comDiaSorin S.p.A. (OTCMKTS:DSRLF) Short Interest UpdateDiaSorin S.p.A. (OTCMKTS:DSRLF - Get Free Report) saw a large decrease in short interest during the month of March. As of March 15th, there was short interest totalling 162,400 shares, a decrease of 25.8% from the February 28th total of 218,900 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is presently ∞ days. Currently, 0.3% of the company's shares are sold short.March 31, 2025 | marketbeat.comDiaSorin S.p.A. (0GZX) Receives a Hold from BarclaysMarch 25, 2025 | markets.businessinsider.comDiaSorin S.p.A. (0GZX) Receives a Sell from Kepler CapitalMarch 19, 2025 | markets.businessinsider.comDiaSorin stock rises despite mixed financial resultsMarch 17, 2025 | in.investing.comDiaSorin S.p.A. (OTCMKTS:DSRLF) Short Interest Up 58.9% in FebruaryDiaSorin S.p.A. (OTCMKTS:DSRLF - Get Free Report) was the recipient of a significant growth in short interest during the month of February. As of February 28th, there was short interest totalling 218,900 shares, a growth of 58.9% from the February 13th total of 137,800 shares. Approximately 0.4% of the shares of the company are short sold. Based on an average daily trading volume, of 100 shares, the days-to-cover ratio is presently 2,189.0 days.March 16, 2025 | marketbeat.comDiaSorin S.p.A. (DSRLF) Q4 2024 Earnings Call TranscriptMarch 14, 2025 | seekingalpha.comItaly's DiaSorin ex-Covid revenue in line with guidanceMarch 14, 2025 | reuters.comUBS Remains a Hold on DiaSorin S.p.A. (0GZX)March 6, 2025 | markets.businessinsider.comKepler Capital Sticks to Its Sell Rating for DiaSorin S.p.A. (0GZX)March 5, 2025 | markets.businessinsider.comDiaSorin S.p.A. (OTCMKTS:DSRLF) Short Interest Up 87.5% in FebruaryDiaSorin S.p.A. (OTCMKTS:DSRLF - Get Free Report) was the recipient of a significant increase in short interest during the month of February. As of February 15th, there was short interest totalling 137,800 shares, an increase of 87.5% from the January 31st total of 73,500 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is currently ∞ days.March 2, 2025 | marketbeat.comDiaSorin (OTCMKTS:DSRLF) Hits New 52-Week High - Here's What HappenedDiaSorin (OTCMKTS:DSRLF) Reaches New 12-Month High - What's Next?March 1, 2025 | marketbeat.comDiaSorin S.p.A. (0GZX) Receives a Hold from RBC CapitalFebruary 27, 2025 | markets.businessinsider.comDiaSorin (OTCMKTS:DSRLF) Sets New 1-Year Low - Should You Sell?DiaSorin (OTCMKTS:DSRLF) Reaches New 52-Week Low - Here's What HappenedFebruary 26, 2025 | marketbeat.comDeutsche Bank sets DiaSorin stock Buy rating, €121 targetFebruary 11, 2025 | msn.comShort Interest in DiaSorin S.p.A. (OTCMKTS:DSRLF) Declines By 8.6%DiaSorin S.p.A. (OTCMKTS:DSRLF - Get Free Report) was the target of a significant decline in short interest in the month of November. As of November 30th, there was short interest totalling 35,100 shares, a decline of 8.6% from the November 15th total of 38,400 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is presently ∞ days.December 16, 2024 | marketbeat.comDiagnostics group DiaSorin's nine-month adjusted core profit up 6%November 5, 2024 | msn.comKepler Capital Reaffirms Their Sell Rating on DiaSorin S.p.A. (0GZX)October 27, 2024 | markets.businessinsider.comDSRLF DiaSorin S.p.A.September 27, 2024 | seekingalpha.comDiaSorin S.p.A. (OTCMKTS:DSRLF) Sees Large Decline in Short InterestDiaSorin S.p.A. (OTCMKTS:DSRLF - Get Free Report) was the recipient of a large decrease in short interest in August. As of August 15th, there was short interest totalling 232,900 shares, a decrease of 25.2% from the July 31st total of 311,500 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is presently ∞ days.August 31, 2024 | marketbeat.comDiaSorin S.p.A. (DSRLF) Q2 2024 Earnings Call TranscriptJuly 31, 2024 | seekingalpha.comDiaSorin SpA ADR (DASOY)May 23, 2024 | investing.comDiasorin SpA DSRLFMay 15, 2024 | morningstar.comDiasorin SpA DIADecember 8, 2023 | morningstar.comDiaSorin S.p.A. reports 1H resultsJuly 27, 2023 | msn.comDiaSorin confirms 2023 guidance after Q1 resultsMay 9, 2023 | msn.comDiaSorin S.p.A.April 6, 2023 | barrons.comDiaSorin S.p.A. (DSRLF) Q4 2022 Earnings Call TranscriptMarch 29, 2023 | seekingalpha.comDiaSorin: Overvalued Italian Healthcare CompanyMarch 4, 2023 | seekingalpha.comCytek(R) Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorinFebruary 15, 2023 | wsj.comCytek® Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorinFebruary 13, 2023 | finance.yahoo.comDIAS.MI - DiaSorin SpA | Stock Price & Latest News | ReutersOctober 31, 2022 | reuters.comDiaSorin S.p.A. (DSRLF) CEO Carlo Rosa on Q2 2022 Results - Earnings Call TranscriptAugust 8, 2022 | seekingalpha.comSouthwest Airlines Company (LUV) stock forecast and price targetOctober 23, 2021 | finance.yahoo.comDiaSorin S.p.A. 2021 Q2 - Results - Earnings Call PresentationAugust 2, 2021 | seekingalpha.com Get DiaSorin News Delivered to You Automatically Sign up to receive the latest news and ratings for DSRLF and its competitors with MarketBeat's FREE daily newsletter. Email Address DSRLF Media Mentions By Week DSRLF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DSRLF News Sentiment▼-0.120.65▲Average Medical News Sentiment DSRLF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DSRLF Articles This Week▼10▲DSRLF Articles Average Week Get DiaSorin News Delivered to You Automatically Sign up to receive the latest news and ratings for DSRLF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Lenovo Group News Amcor News Tri-Continental News General American Investors News BlackRock MuniYield Quality Fund News BlackRock MuniYield Quality Fund III News Invesco Municipal Opportunity Trust News Invesco Value Municipal Income Trust News Western Asset Managed Municipals Fund News Invesco Trust for Investment Grade Municipals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:DSRLF) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DiaSorin S.p.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share DiaSorin With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.